Thus, these findings reveal a strong link between aberrant STMN2 expression and MN degeneration in ALS and imply that restoring STMN2 levels is a promising therapeutic approach for TDP-43-dependent ALS. Here, TARDBP is linked to amyotrophic lateral sclerosis.